“Reawakening Latent Viruses: HIV and Epstein-Barr Virus”
- Science for Admin
Kristin Keck, PhD, is a postdoctoral scholar in the Miranda lab.
Education: BS Duke University; PhD University of Virginia, Department of Microbiology, Immunology, and Cancer Biology
Project Description: Epstein-Barr virus causes infectious mononucleosis and is implicated in the development of many cancers. Her current project is focused on a class of drugs that suppress reactivation of latent Epstein-Barr virus, which means these drugs prevent the virus from shifting from an inactive to an active/replicating state. Whereas currently used antivirals block a single step in the viral life cycle, they have discovered that these drugs actually block the virus at two different stages of its life cycle. Drugs like these could be yield greater efficacy and decreased risk of viral resistance.